Bar Harbor Wealth Management Gilead Sciences, Inc. Transaction History

Bar Harbor Wealth Management

$1.55 Billion
Q3 2024

A detailed history of Bar Harbor Wealth Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bar Harbor Wealth Management holds 3,249 shares of GILD stock, worth $286,171. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,249

Previous 3,249 -0.0%

Holding current value

$286,171

Previous $222,000 22.52%

% of portfolio

0.02%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 17, 2024	SELL	$63.15 - $72.88 $32,774 - $37,824	-519 Reduced 13.77%	3,249 $222,000
Q1 2024 Apr 23, 2024	SELL	$71.58 - $87.29 $17,895 - $21,822	-250 Reduced 6.22%	3,768 $276,000
Q4 2023 Jan 17, 2024	SELL	$73.27 - $83.09 $14,654 - $16,618	-200 Reduced 4.74%	4,018 $325,000
Q3 2023 Nov 28, 2023	SELL	$73.94 - $80.67 $4,066 - $4,436	-55 Reduced 1.29%	4,218 $316,000
Q4 2022 Jan 19, 2023	SELL	$62.32 - $89.47 $34,276 - $49,208	-550 Reduced 11.4%	4,273 $367,000
Q3 2022 Oct 24, 2022	SELL	$59.54 - $68.01 $119 - $136	-2 Reduced 0.04%	4,823 $298,000
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $278,499 - $313,673	4,825 New	4,825 $298,000
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $255,467 - $327,217	-4,079 Closed	0 $0
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $372,677 - $409,933	-6,048 Reduced 59.72%	4,079 $265,000
Q3 2019 Nov 07, 2019	BUY	$62.51 - $69.0 $5,938 - $6,555	95 Added 0.95%	10,127 $642,000
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $54,383 - $60,985	-879 Reduced 8.06%	10,032 $678,000
Q1 2019 May 10, 2019	SELL	$62.53 - $70.05 $24,011 - $26,899	-384 Reduced 3.4%	10,911 $709,000
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $183,617 - $239,607	-3,033 Reduced 21.17%	11,295 $707,000
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $6,629 - $7,339	93 Added 0.65%	14,328 $1.11 Million
Q2 2018 Aug 10, 2018	SELL	$64.88 - $75.68 $115,421 - $134,634	-1,779 Reduced 11.11%	14,235 $1.01 Million
Q1 2018 Apr 06, 2018	BUY	$72.84 - $88.8 $87,917 - $107,181	1,207 Added 8.15%	16,014 $1.21 Million
Q4 2017 Jan 17, 2018	BUY	$71.15 - $83.52 $315,407 - $370,244	4,433 Added 42.73%	14,807 $1.06 Million
Q3 2017 Oct 11, 2017	BUY	$72.11 - $85.47 $748,069 - $886,665	10,374	10,374 $840,000

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

9.04M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bar Harbor Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bar Harbor Wealth Management with notifications on news.

Account

Bar Harbor Wealth Management Gilead Sciences, Inc. Transaction History